StartUp Health December 10, 2024
Nicole Kinsey

StartUp Health company Cala Health’s products are the only FDA-cleared, clinically validated noninvasive devices for the relief of hand tremors, allowing patients with essential tremor to return to the moments that matter. This new funding will propel Cala’s commercialization trajectory, notably with the recent positive Medicare Coverage Determination for Cala TAPS™ (Transcutaneous Afferent Patterned Stimulation) Therapy.

Cala Health, a San Mateo, CA-based non-invasive bioelectronic medicine company in the StartUp Health community, raised $50M led by Vertex Growth Fund and Nexus NeuroTech Ventures, with participation from Action Potential, Johnson & Johnson, Lightstone, Lux, GV (Google Ventures), OSF Ventures, Ascension Ventures, TriVentures, Reimagined Ventures, Peak6, and Fiscus. source>

Other health innovation funding reported this week included:

Cleerly, a Denver, CO-based AI-powered cardiovascular...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Digital Health, Investments, Technology, Trends
Walmart and Amazon Expand AI Investments to Boost Efficiency
Jensen Huang says investors got it wrong over DeepSeek stock selloff that wiped $600B from Nvidia
Walgreens PE deal back on the table: 5 things to know
Anne Wojcicki has a new offer to take 23andMe private, this time for $74.7 million
Australia infuses $85M in digital mental health and more briefs

Share This Article